On the afternoon of September 27, in order to promote the smooth progress of the construction of the hospital's national drug clinical trial institution, the Nanchang Purui Ophthalmology Hospital's national drug and medical device clinical trial organization launch meeting and the drug clinical trial quality management specification training meeting were successfully held in the conference hall on the third floor of the hospital. Professor Yifan, the First Affiliated Hospital of Nanchang University, the Jiangxi Provincial Hospital of Traditional Chinese Medicine, and the former second-level inspector registration department of the Provincial Drug Administration, Professor Liu Jianfang, the Party Secretary of the Nanchang Hongdu Hospital of Traditional Chinese Medicine, and the National Drug Administration, and the Professor Liu Jianfang, the current vice dean of the School of Pharmacy of Nanchang University, the Jiangxi Jinggang Scholars Special Professor, Jiangxi Province "Double Thousand" Program, and the Jiangxi Province Hundred Thousand Talents Project candidate, Yang Haijun, the President of Nanchang Prere Ophthalmology Hospital, and Ye Zhigang, the Party Secretary and Executive Director of Nanchang Prere Ophthalmology Hospital, attended the meeting. The heads of various administrative functional departments of the hospital, the heads of the clinical and medical technology departments, and the head nurses, and the members of the first batch of research groups of the drug and medical device test professional departments attended the meeting. Zou Lei, director of the Medical Department of Nanchang Prere Ophthalmology Hospital, presided over the meeting.
Nanchang Purui Eye Hospital National Drug and Medical Device Clinical Trial Institution Launch Conference
Director Yang Haijun delivered a speech and delivered a mobilization speech
At the launch meeting, President Yang Haijun delivered a speech and made a mobilization speech on the formal launch of the registration work of the National Drug and Medical Device Clinical Trial Institution of the hospital. He expressed his sincere welcome to the arrival of all the experts and expressed his sincere gratitude to the experts who care and support the development of the hospital. He pointed out that applying for clinical trial institutions for drugs and medical devices is of great significance to the development of the hospital. It is not only conducive to improving the hospital's scientific research level and comprehensive strength, but also conducive to promoting the development and construction of disciplines. With the country's strong support for the pharmaceutical industry and the rapid development of new drug development, hospitals will have more opportunities to carry out drug clinical trials. Nanchang Purui Ophthalmology Hospital will fully attach importance to the construction of drug clinical trial institutions, strengthen responsibility, consolidate filing work, earnestly study and implement GCP, do their best and work together to successfully complete the organizational construction work. We have made unremitting efforts to improve the hospital's scientific research level and improve the hospital's comprehensive strength.
Professor Yifan teaches "Introduction to the new version of drug clinical trial quality management specifications"
Professor Liu Jianfang teaches "Quality Management Elements of Drug Clinical Trials"
Professor Xia Chunhua teaches "The Key Points of Phase II and III Clinical Trial Design"
At the training meeting, Professor Yifan, former Director of the Registration Office of the Second-level Inspector of the Provincial Drug Administration, Hongdu, Nanchang City Professor Liu Jianfang, Party Secretary of the Hospital of Traditional Chinese Medicine and Expert on Drug Clinical Trial Data Verification of the State Drug Administration, Professor Xia Chunhua, Distinguished Professor of Jinggang Scholars in Jiangxi Province, Selected for the "Double Thousand" Plan in Jiangxi Province, and Selected for the Hundred Thousand Talents Project in Jiangxi Province, gave lectures on related topics such as "Introduction to the Quality Management Specifications for the New Version of Drug Clinical Trials", "Quality Management Elements of Drug Clinical Trials", "Major Points for Phase II and III Clinical Trial Design Points". The lecture content is rich and exciting, systematic and comprehensive, and it inspires everyone's enthusiasm for learning with practical case sharing and vivid and interesting interactive methods.
On-site assessment After the training, the hospital conducted relevant training assessments on the spot for all students. Through the assessment and testing the training effect, they encouraged and motivated them to check for omissions, enhance their learning awareness, and strive to do better. The students expressed that through this training, they had a more comprehensive understanding of the quality management standards of drug clinical trials, and they also became more clear about their future responsibilities and how to carry out drug clinical trial projects in a standardized manner. At the same time, this training also gave the hospital a lot of guidance and inspiration in the construction and operation management of national drug clinical trial institutions.
This training session further strengthened the clinical trial personnel's awareness of drug clinical trial quality management standards and ethics and ethics awareness, improved the clinical trial technology level of clinical trial personnel, continuously standardized the clinical trial process of drugs and medical devices, protected the rights and interests and safety of subjects, and ensured the quality of clinical trials.
Participation in the national drug and medical device clinical trial project is one of the important ways for medical institutions to improve the level of medical research and enhance the comprehensive capabilities of medical personnel. The successful holding of this meeting marks the official launch of the qualification filing of the national drug clinical trial institution in Nanchang Purui Eye Hospital. The hospital will enrich and supplement the comprehensive management content of the hospital through the National Drug and Medical Device Clinical Trial Project, promote the continuous progress and development of the hospital's medical research work, give full play to the comprehensive advantages of integrating medicine, education and research. Taking this conference as an opportunity, we will do a meticulous and solid job in the application and training of drug and medical device clinical trial institutions, ensure that the various processes of clinical trial institutions are rigorous, orderly and authentic, and strive to obtain the qualifications of national drug and medical device clinical trial institutions as soon as possible, seek welfare for the people's eye health in Heroes City, and contribute to the innovative development of the medical industry.
Editor: Liu Jianwu
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-